GOED reports that The Omega-3 Coalition began test-marketing its full campaign last week.
As part of its plan to educate consumers on the benefits of omega-3 fatty acids EPA and DHA, the Global Organization for EPA and DHA Omega-3s (GOED; Salt Lake City, UT) and its newly formed Omega-3 Coalition have launched a consumer website, www.alwaysomega3s.com.
Site features include a quiz to help consumers estimate their average daily intake of EPA and DHA omega-3, a guide to choosing foods and supplements containing EPA and DHA, and basic information and scientific documentation about the benefits of omega-3s for the heart, brain, eyes, and joints.
The independent educational website is supported by The Omega-3 Coalition, a recently forged group whose goal is, in part, to help reverse omega-3s’ yearlong market decline and “change the tone of the conversation around omega-3s in the mainstream media.” Read more about the coalition and GOED's advice to omega-3 companies in the face of current market struggles.
GOED reports that the coalition began test-marketing its full campaign last week. “This test market will take place for approximately one month and lays the groundwork for the national rollout planned for early 2015,” it says. The coalition is also fundraising to support its efforts, with an estimated $3.5 million raised as of August.
Read more about the current omega-3 market slump.
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine jennifer.grebow@ubm.com
Photo © iStockphoto.com/Juxtagirl
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.